The store will not work correctly when cookies are disabled.
1-(4-(2-methylallyloxy)phenyl)-3-phenylurea
ID: ALA4860146
PubChem CID: 17097609
Max Phase: Preclinical
Molecular Formula: C17H18N2O2
Molecular Weight: 282.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C=C(C)COc1ccc(NC(=O)Nc2ccccc2)cc1
Standard InChI: InChI=1S/C17H18N2O2/c1-13(2)12-21-16-10-8-15(9-11-16)19-17(20)18-14-6-4-3-5-7-14/h3-11H,1,12H2,2H3,(H2,18,19,20)
Standard InChI Key: MBFOSWDNFUUHSD-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
9.1151 -27.0162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1139 -27.8435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8288 -28.2564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5452 -27.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5423 -27.0126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8270 -26.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2603 -28.2545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9741 -27.8409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6892 -28.2522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4031 -27.8386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9728 -27.0159 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1168 -28.2514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8301 -27.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8292 -27.0126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1091 -26.6014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3988 -27.0166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5426 -26.5980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2582 -27.0084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9715 -26.5938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6871 -27.0043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9691 -25.7688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
8 11 2 0
10 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 10 1 0
14 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.34 | Molecular Weight (Monoisotopic): 282.1368 | AlogP: 4.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 50.36 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.68 | CX Basic pKa: ┄ | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: -1.19 |
References
1. (2020) Inhibitors of GPR174 and Uses Thereof, |
2. (2020) Methods and Compositions for Treating Cancer, |